Leveraging rapid technological advances for human health is a global trend, driving the rise of biomedical engineering ...

H ave you noticed people everywhere wearing continuous glucose monitors (CGM)? On the subway, at the gym, in the grocery ...

The FDA cleared Eversense 365 as the first 1-year integrated continuous glucose monitoring (CGM) system for adults with type ...

Eversense 365 is a fully-implantable CGM with a 365-day sensor, making it the first 1-year CGM option for diabetes management ...

With the company's market cap of $28 billion today, it's important to recognize that DexCom (NASDAQ: DXCM) is already one of ...

If a patient receives a continuous glucose monitor device through their medical benefit, they may be more adherent and may ...

After collecting FDA green lights for 90- and 180-day versions, the agency has cleared the latest generation of the Eversense ...

Continuous glucose monitoring, compared with fingerstick tests, was feasible and accurate in an inpatient setting among patients and nurses.

Remote patient monitoring has exploded since the pandemic. In just four years from the beginning of 2019 through 2022, ...

The number of people living with Parkinson's disease globally has doubled in the past 25 years. Yet the treatment and ...

(MENAFN- GlobeNewsWire - Nasdaq) The Continuous Glucose Monitoring market is Growing at a CAGR of 7.80%, Driven by the Increasing Prevalence of Prediabetes and a Rising Demand for Monitoring ...

Implementation of continuous glucose monitoring (CGM ... The researchers also administered a System Usability Scale questionnaire to nurses who engaged with the CGM policy, whereas patients ...